Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - OPERATING EXPENSES
Operating Expenses ESPR - Esperion Therapeutics, Inc.
229 M
LAST VALUE
-11.36%
2 YEAR CAGR
2.25%
5 YEAR CAGR
25.95%
10 YEAR CAGR